Fazel Seena, Wolf Achim, Palm Camilla, Lichtenstein Paul
Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK (S Fazel MD, A Wolf MSc); and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (C Palm MSc, Prof P Lichtenstein PhD).
Lancet Psychiatry. 2014 Jun;1(1):44-54. doi: 10.1016/S2215-0366(14)70223-8.
People with schizophrenia and related disorders are at an increased risk of adverse outcomes, including conviction of a violent offence, suicide, and premature mortality. However, the rates of, and risk factors for, these outcomes need clarification as a basis for population-based and targeted interventions. We aimed to determine rates and risk factors for these outcomes, and investigate to what extent they are shared across outcomes and are specific to schizophrenia and related disorders.
We undertook a total population cohort study in Sweden of 24 297 patients with schizophrenia and related disorders between January, 1972 and December, 2009. Patients were matched by age and sex to people from the general population (n=485 940) and also to unaffected sibling controls (n=26 357). First, we investigated rates of conviction of a violent offence, suicide, and premature mortality, with follow-up until conviction of a violent offence, emigration, death, or end of follow-up (Dec 31, 2009), whichever occurred first. Second, we analysed associations between these adverse outcomes and sociodemographic, individual, familial, and distal risk factors, for men and women separately, with Cox proportional hazards models. Finally, we assessed time trends in adverse outcomes between 1972 and 2009, for which we compared patients with unaffected siblings, and analysed associations with changes in the number of nights spent in inpatient beds in psychiatric facilities nationwide.
Within 5 years of their initial diagnosis, 13·9% of men and 4·7% of women with schizophrenia and related disorders had a major adverse outcome (10·7% of men and 2·7% of women were convicted of a violent offence, and 3·3% of men and 2·0% of women died prematurely of any cause). During the study, the adjusted odds ratio of any adverse outcomes for patients compared with general population controls was 7·5 (95% CI 7·2-7·9) in men and 11·1 (10·2-12·1) in women. Three risk factors that were present before diagnosis were predictive of any adverse outcome: drug use disorders, criminality, and self-harm, which were also risk factors for these outcomes in unaffected siblings and in the general population. Over the period 1973-2009, the odds of these outcomes increased in patients with schizophrenia and related disorders compared with unaffected siblings.
Schizophrenia and related disorders are associated with substantially increased rates of violent crime, suicide, and premature mortality. Risk factors for these three outcomes included both those specific to individuals with schizophrenia and related disorders, and those shared with the general population. Therefore, a combination of population-based and targeted strategies might be necessary to reduce the substantial rates of adverse outcomes in patients with schizophrenia and related disorders.
精神分裂症及相关障碍患者出现不良后果的风险增加,包括暴力犯罪定罪、自杀和过早死亡。然而,这些后果的发生率及其风险因素需要明确,作为基于人群和有针对性干预措施的基础。我们旨在确定这些后果的发生率和风险因素,并调查它们在不同后果之间的共享程度以及精神分裂症及相关障碍所特有的因素。
我们在瑞典对1972年1月至2009年12月期间的24297例精神分裂症及相关障碍患者进行了全人群队列研究。患者按年龄和性别与普通人群(n = 485940)以及未患病的同胞对照(n = 26357)进行匹配。首先,我们调查暴力犯罪定罪、自杀和过早死亡的发生率,随访至暴力犯罪定罪、移民、死亡或随访结束(2009年12月31日),以先发生者为准。其次,我们分别用Cox比例风险模型分析这些不良后果与社会人口学、个体、家族和远端风险因素之间的关联,男女分开分析。最后,我们评估了1972年至2009年期间不良后果的时间趋势,为此我们将患者与未患病的同胞进行比较,并分析与全国精神科住院床位过夜天数变化的关联。
在精神分裂症及相关障碍患者首次诊断后的5年内,13.9%的男性和4.7%的女性出现了严重不良后果(10.7%的男性和2.7%的女性有暴力犯罪定罪,3.3%的男性和2.0%的女性因任何原因过早死亡)。在研究期间,与普通人群对照相比,患者出现任何不良后果的校正比值比在男性中为7.5(95%CI 7.2 - 7.9),在女性中为11.1(10.2 - 12.1)。诊断前存在的三个风险因素可预测任何不良后果:药物使用障碍、犯罪行为和自我伤害,这些因素在未患病的同胞和普通人群中也是这些后果的风险因素。在